Nu-Life Solutions

Raising $3mil to take Nu-V3, neuromodulation device to the global marketplace

Facebook Twitter LinkedIn

Nu-V3 is the only non-invasive, non-pharmaceutical neuromodulation device to offer short and long term relief from pain, anxiety, depression and sleeplessness while also mitigating or elimination the need for pain medications, particularly opioids.  Nu-V3 works through micro stimulation of the cranial nerves in a safe, effective, simple to wear device.  Nu-V3 is miniaturized, is worn 24/7 and allows for almost any everyday activity. 

For detailed information on Nu-V3, the science behind the technology, our market entry plan and meet our Executive and Executive Medical Team, please visit:  Nu-V3.com

Nu-V3 was invented by Jim Robertson, Founder and CEO of Nu-Life Solutions in 2011 and been through many updates and feasibility tests to be sure the patient has the greatest possibility for success.   Success means a dramatic reduction in the symptoms of acute and chronic pain, anxiety, depression and sleeplessness along with an increased level of activity and improved overall quality of life.  The mitigation of addictive medications is a benefit that is realized across almost all patient populations.

Nu-V3 is:
  • Patented in the United States, Europe, Japan, Latin America and Canada, trademark registered in more than 50 countries.
  • Clinically proven with an average of 70% reductions in symptoms both short and long term
  • Production ready and full able to scale to meet demand
  • In final stages of regulatory clearances for the United States, soon to be followed by Europe, Japan, Latin America and Canada
  • Prepared to enter the market in the United States in 2021, soon to be followed by Europe, Japan, Latin America and Canada
The Nu-Life Solutions Executive Medical Team is preparing to execute a number of clinical programs designed to demonstrate the efficacy, ease of use and cost effectiveness for symptom management of pain, anxiety, depression and sleeplessness while lessening the need for pain medication.  In addition, the science behind Nu-V3 supports expended use to include:
  • Pre and post op surgery and recovery
  • Pain management, injury recovery and performance improvement for elite athletes and active military
  • Neurodegenerative disease such as Parkinson's, Alzheimers and ALS 
For more on the science behind Nu-V3:  https://www.nu-v3.com/copy-of-the-science-of-nu-v3

Investment flyers, Executive Summary and pitch are all available upon request.  We also find that an effective way to understand the Nu-Life and Nu-V3 opportunity, is to have direct call with the Founder and CEO of the company.  To do so:

Please contact Jim Robertson:  [email protected]

Ready to Ask For Funding for your company?

Post a Funding Request

Nu-Life Solutions is no longer seeking funding.